This Biopharma Company Is Tackling Diseases That Badly Need Solutions

Sign up for this week’s All Access giveaway here

Laxminarayan Bhat, Founder, President and CEO of Reviva Pharmaceuticals Holdings Inc RVPH was a guest on Benzinga’s All Access on October 21, 2022.

Headquartered in Cupertino, California, Reviva is a clinical-stage biopharmaceutical company that discovers, develops and seeks to commercialize next-generation therapeutics for diseases representing significant unmet medical needs and burden to society, patients, and their families. 

Watch the full interview here:

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.


 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: BiotechGeneralBenzinga All AccessPartner ContentReviva Pharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!